Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Type v hyperlipidaemia: Which Medications Cause It? (345 Reports Across 53 Drugs)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Type v hyperlipidaemia has been reported as an adverse event with 53 different drugs in the FDA's FAERS database, with 345 total reports. 20 of these reports resulted in death.The drugs most commonly associated with Type v hyperlipidaemia are SACUBITRIL\VALSARTAN, ASPIRIN, and CARVEDILOL.

345
Total Reports
53
Drugs Involved
20
Deaths
121
Hospitalizations
64.7 yrs
Average Patient Age
48.7% / 51.3%
Female / Male

Which Drugs Cause Type v hyperlipidaemia Most Often?

Drug Reports % of Drug Reports Deaths Hosp. Life-Threat.
SACUBITRIL\VALSARTAN 25 0.0% 0 4 0
ASPIRIN 24 0.0% 0 3 0
CARVEDILOL 23 0.2% 0 4 0
ATORVASTATIN 22 0.0% 0 2 0
RAMIPRIL 22 0.1% 0 3 0
ALENDRONATE 21 0.1% 3 19 0
DAPAGLIFLOZIN 21 0.1% 0 0 0
ALLOPURINOL 19 0.1% 0 0 0
EPLERENONE 19 0.5% 0 0 0
EZETIMIBE 19 0.1% 0 0 0
METFORMIN 19 0.0% 0 0 0
TORSEMIDE 19 0.2% 0 0 0
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE 16 8.7% 0 0 0
DENOSUMAB 15 0.0% 1 1 0
PREDNISONE 15 0.0% 0 8 0
FINASTERIDE 13 0.1% 0 4 0
LEFLUNOMIDE 13 0.0% 0 7 0
SITAGLIPTIN 12 0.1% 6 10 5
TEPROTUMUMAB-TRBW 12 0.2% 0 2 0
ADALIMUMAB 11 0.0% 0 2 0

View all 53 drugs →

Top 3 Drugs Associated With Type v hyperlipidaemia

24 reports
23 reports

Related Side Effects

Drug ineffective (1,049,718) Off label use (762,782) Death (660,423) Fatigue (599,248) Nausea (562,301) Diarrhoea (491,550) Pain (471,975) Headache (460,069) Dyspnoea (409,496) Dizziness (352,922)